Seeing and Striking the Target: How PSMA Is Transforming Prostate Cancer Care
Prostate cancer research in 2026 has been defined by a single molecule: PSMA, or prostate-specific membrane antigen. This protein sits […]
Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for […]
August 2022
Includes: 50/50 Fundraising Raffle, Transforming Cancer Treatment with a Tablespoon of Blood, Best Prostate Biopsy Techniques in 2022, Prostate Cancer Virtual Conference, and more!